R&D Scope for action: How the life sciences industry can make pr... With the next global climate conference, COP28 in Dubai, having begun on 30th November, many businesses have been taking stock of their own record.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face